140 related articles for article (PubMed ID: 35779355)
1. Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes.
Lucio-Gutiérrez JR; Cordero-Pérez P; Farías-Navarro IC; Tijerina-Marquez R; Sánchez-Martínez C; Ávila-Velázquez JL; García-Hernández PA; Náñez-Terreros H; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Torres-González L; Waksman-Minsky NH; Saucedo AL
J Pharm Biomed Anal; 2022 Sep; 219():114885. PubMed ID: 35779355
[TBL] [Abstract][Full Text] [Related]
2. Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
Lucio-Gutiérrez JR; Cordero-Pérez P; Ávila-Velázquez JL; Torres-González L; Farías-Navarro IC; Govea-Torres G; Sánchez-Martínez C; García-Hernández PA; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Waksman-Minsky NH; Saucedo AL
J Pharm Biomed Anal; 2024 Sep; 247():116240. PubMed ID: 38820837
[TBL] [Abstract][Full Text] [Related]
3. Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.
Luck M; Bertho G; Bateson M; Karras A; Yartseva A; Thervet E; Damon C; Pallet N
PLoS One; 2016; 11(11):e0166905. PubMed ID: 27861591
[TBL] [Abstract][Full Text] [Related]
4. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
5. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy.
Qi S; Ouyang X; Wang L; Peng W; Wen J; Dai Y
Clin Transl Sci; 2012 Oct; 5(5):379-85. PubMed ID: 23067349
[TBL] [Abstract][Full Text] [Related]
6. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
7. 1H NMR-based metabolite profiling of plasma in a rat model of chronic kidney disease.
Kim JA; Choi HJ; Kwon YK; Ryu DH; Kwon TH; Hwang GS
PLoS One; 2014; 9(1):e85445. PubMed ID: 24465563
[TBL] [Abstract][Full Text] [Related]
8. Urinary Metabolomics Study of Patients with Bicuspid Aortic Valve Disease.
Chessa M; Panebianco M; Corbu S; Lussu M; Dessì A; Pintus R; Cesare Marincola F; Fanos V
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299495
[TBL] [Abstract][Full Text] [Related]
9. Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency.
Mika A; Wojtowicz W; Ząbek A; Młynarz P; Chmielewski M; Sledzinski T; Stepnowski P
J Pharm Biomed Anal; 2018 Feb; 149():1-8. PubMed ID: 29100025
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes.
Lee J; Choi JY; Kwon YK; Lee D; Jung HY; Ryu HM; Cho JH; Ryu DH; Kim YL; Hwang GS
Clin Chim Acta; 2016 Aug; 459():123-131. PubMed ID: 27221201
[TBL] [Abstract][Full Text] [Related]
11. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Magnetic Resonance-Based Metabolomics Approach Revealed the Intervention Effect of Using Complementary and Alternative Medicine (CAM) by CKD Patients.
Gupta N; Yadav DK; Gautam S; Kumar A; Kumar D; Prasad N
ACS Omega; 2023 Feb; 8(8):7722-7737. PubMed ID: 36872986
[TBL] [Abstract][Full Text] [Related]
13. 1H-NMR-based metabolomics study of cerebral infarction.
Jung JY; Lee HS; Kang DG; Kim NS; Cha MH; Bang OS; Ryu DH; Hwang GS
Stroke; 2011 May; 42(5):1282-8. PubMed ID: 21474802
[TBL] [Abstract][Full Text] [Related]
14. [Study on Urinary Metabolic Profile in Rats with Deep Venous Thrombosis Based on Pattern Recognition].
Cao J; Lü XG; Li Y; Jin QQ; Chu XY; Wang YY; Sun JH
Fa Yi Xue Za Zhi; 2018 Jun; 34(3):228-232. PubMed ID: 30051657
[TBL] [Abstract][Full Text] [Related]
15. A molecular signature for the metabolic syndrome by urine metabolomics.
Bruzzone C; Gil-Redondo R; Seco M; Barragán R; de la Cruz L; Cannet C; Schäfer H; Fang F; Diercks T; Bizkarguenaga M; González-Valle B; Laín A; Sanz-Parra A; Coltell O; de Letona AL; Spraul M; Lu SC; Buguianesi E; Embade N; Anstee QM; Corella D; Mato JM; Millet O
Cardiovasc Diabetol; 2021 Jul; 20(1):155. PubMed ID: 34320987
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Surface-Enhanced Raman Scattering Properties of Serum and Urine for the Detection of Chronic Kidney Disease in Patients.
Zong M; Zhou L; Guan Q; Lin D; Zhao J; Qi H; Harriman D; Fan L; Zeng H; Du C
Appl Spectrosc; 2021 Apr; 75(4):412-421. PubMed ID: 33031004
[TBL] [Abstract][Full Text] [Related]
17. Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock.
Mickiewicz B; Duggan GE; Winston BW; Doig C; Kubes P; Vogel HJ;
Crit Care Med; 2014 May; 42(5):1140-9. PubMed ID: 24368342
[TBL] [Abstract][Full Text] [Related]
18. NMR-based metabolomics associated with chronic kidney disease in humans and animals: a one health perspective.
Hunter E; Percival B; Ahmad Z; Chang MW; Hunt JA; Tasker S; De Risio L; Wilson PB
Mol Cell Biochem; 2021 Nov; 476(11):4133-4137. PubMed ID: 34312783
[TBL] [Abstract][Full Text] [Related]
19. NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db mice.
Mora-Ortiz M; Nuñez Ramos P; Oregioni A; Claus SP
Metabolomics; 2019 Jun; 15(6):89. PubMed ID: 31179513
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
